Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sophim is a French manufacturer specializing in the production of natural ingredients for the cosmetic and pharmaceutical industries. The company is a global leader in the production of olive-derived squalane, marketed under the brand Phytosqualan, which serves as a sustainable alternative to shark-derived squalane. Beyond cosmetics, Sophim provides pharmaceutical-grade squalane used as an excipient or in the formulation of vaccine adjuvants. Their expertise includes oleochemical processes such as distillation, esterification, and hydrogenation. The company operates manufacturing facilities in France and Spain, emphasizing circular economy principles by upcycling olive oil industry by-products. Sophim's products are widely used in skincare, sun care, and makeup formulations globally.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sophim.